Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. (CATX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CATX · as of Jun 8, 2026
Key Statistics
Explore Perspective Therapeutics, Inc. Data
catx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 81.8%
The CATX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $13.33, representing +339.93% upside from the current price of $3.03.
Competitors & Peers
catx competitorsCATX
AVR
ELMD
HSDT
IVVD
MXCTStock Performance
Full HistoryAbout Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant di…
what is perspective therapeutics, inc. · catx stock overview · perspective therapeutics, inc. company profile · who is perspective therapeutics, inc. ceo · catx AMEX · perspective therapeutics, inc. headquarters · perspective therapeutics, inc. business segments
About Stock Overview & Key Data
Perspective Therapeutics, Inc. (CATX) is a Healthcare company in the Medical - Devices industry, listed on AMEX since Nov 10, 2005. As of the latest trading session, CATX stock price is $3.03, with a market capitalization of $234.1M. The stock has returned -6.19% over the past 12 months and +10.18% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Perspective Therapeutics, Inc. stock is Buy, with an average 12-month price target of $13.33. In fiscal year 2025, Perspective Therapeutics, Inc. reported revenue of — and net income of -$103.1M. For detailed data — including Perspective Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Perspective Therapeutics, Inc. (CATX) stock price is $3.03. The stock is traded on AMEX under the ticker symbol CATX. The 52-week range is $1.96 – $6.16.